يعرض 1 - 20 نتائج من 4,902 نتيجة بحث عن '(( significant benefits decrease ) OR ( significantly ((teer decrease) OR (greater increase)) ))', وقت الاستعلام: 0.53s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    Summary map of all contacts with statistically significant SVM classifications. حسب Alexander P. Rockhill (6053618)

    منشور في 2024
    "…<p>The top row presents the proportion of significant SVM clusters. It illustrates what proportions of channels are significant at that time-frequency ranging from 0 to 1. …"
  4. 4
  5. 5
  6. 6
  7. 7

    Nodes with eccentricity values greater than 7. حسب Xizhen Xu (476895)

    منشور في 2025
    "…<div><p>Prefabricated buildings face greater and different prefabricated components throughout their entire lifecycle, leading to a significant increase in management difficulty. …"
  8. 8

    Greater increases in rsFC after 24-week treatment in the DM-INI group (n  حسب Zongpai Zhang (21395627)

    منشور في 2025
    "…The DM-INI group exhibited significantly greater increases in rsFC in the regions: (a) the mPFC with the lPOC, (b) the lHPC with the middle/superior frontal cortex, (c) the HPC rsFC with the lPOC, and (d) the rHPC rsFC with the middle/superior frontal cortex. …"
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. حسب Luqiong Liu (11537092)

    منشور في 2024
    "…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. (<b>B)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on day 22. …"
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"
  19. 19

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"
  20. 20

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"